Filing Flows › Glaukos (GKOS) › Q1 2025
Glaukos (GKOS) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 1, 2025
Glaukos (GKOS) reported revenue of $107M for the first quarter 2025 (Q1 2025), +25% from a year earlier and +1% from the quarter before. Operating margin was -19.4%, net loss $18.1M (17.0% of revenue).
Glaukos, Q1 2025: revenue $107M (+25% year over year), operating margin -19.4%, net loss $18.1M, operating cash flow −$18.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $107M | +1% | +25% |
| Operating profit | −$20.7M | — | — |
| Net earnings | −$18.1M | — | — |
| Operating cash flow | −$18.5M | — | — |
What changed
Revenue was $106.7M in Q1 2025, up 25% year over year and up 1% from the previous quarter. Glaucoma was the largest line at 83% of revenue. Glaucoma added $20.9M year over year (up 31%), 99% of the total change.
Gross margin was 77.2%, up 0.9 points from a year earlier. Operating costs exceeded revenue by $20.7M, an operating margin of -19.4%. Operating expenses fell 1% while revenue rose 25%. The fastest-growing cost line was SG&A (+14%). The quarter ended with a net loss of $18.1M, narrower than the previous quarter's $33.6M loss.
Operating cash flow was −$18.5M. Non-cash charges added back $8.2M of depreciation and amortization and $13.0M of share-based compensation. Working capital and other items used $21.6M. Capital expenditures of $1.9M exceeded it, leaving free cash flow of −$20.5M.
Questions
What was Glaukos' revenue in the first quarter 2025?
Glaukos (GKOS) reported revenue of $107M for the first quarter 2025 (Q1 2025), +25% from a year earlier and +1% from the quarter before.
Was Glaukos profitable in the first quarter 2025?
Operating loss was $20.7M (-19.4% of revenue) and net loss $18.1M.
Source: Glaukos 10-Q on SEC EDGAR.